脑白质病变与内分泌因素的研究进展
Research Progress on White Matter Lesions and Endocrine Factors
DOI: 10.12677/ACM.2023.1361301, PDF,   
作者: 杨雅婷:青海大学研究生院,青海 西宁;冶学兰:青海大学附属医院神经内科,青海 西宁
关键词: 脑白质病变内分泌因素糖尿病甲状腺激素雌激素White Matter Lesions Endocrine Factors Diabetes Thyroid Hormone Estrogen
摘要: 脑白质病变(White matter lesions, WML)发病率高、起病隐匿、易被忽略,也是脑小血管病(Cerebral Small Vessel Disease, CSVD)最常见的一种影像学标志。近年来的研究发现内分泌功能也与脑白质病变的发生密切相关,对脑白质病变的治疗、预后、病因识别等方面具有独特的优势,内分泌功能异常是心脑血管损伤重要且可以干预的危险因素。其中,糖尿病作为脑白质病变的危险因素,其他内分泌因素包括甲状腺功能、雌激素等也可能与脑白质病变有关。本文就脑白质病变与糖尿病、甲状腺激素、雌激素等内分泌因素的联系做一综述,全面总结脑白质病变在内分泌功能方面的研究进展。
Abstract: The incidence rate of leukoencephalopathy is high, its onset is hidden, and it is easy to be ignored. It is also the most common imaging marker of cerebral small vessel disease (CSVD). In recent years, research has found that endocrine function is also closely related to the occurrence of white matter lesions, and has unique advantages in the treatment, prognosis, and etiology identification of white matter lesions. Abnormal endocrine function is an important and interventable risk factor for car-diovascular and cerebrovascular injury. Among them, diabetes is a risk factor for leukoencephalo-pathy, and other endocrine factors, including thyroid function, estrogen, glucocorticoid receptor polymorphism, may also be related to leukoencephalopathy. This article reviews the relationship between leukoencephalopathy and endocrine factors such as diabetes, thyroid hormone, estrogen, and comprehensively summarizes the research progress of leukoencephalopathy in endocrine.
文章引用:杨雅婷, 冶学兰. 脑白质病变与内分泌因素的研究进展[J]. 临床医学进展, 2023, 13(6): 9292-9300. https://doi.org/10.12677/ACM.2023.1361301

参考文献

[1] 赵梦娇, 赵玉华. 脑小血管病的流行病学概况[J]. 西藏医药, 2018(6): 143-145.
[2] Zwanenburg, J.J.M. and van Osch, M.J.P. (2017) Targeting Cerebral Small Vessel Disease with MRI. Stroke, 48, 3175-3182. [Google Scholar] [CrossRef
[3] Wardlaw, J.M., Valdes Hernandez, M.C. and Munoz-Maniega, S. (2015) What Are White Matter Hyperintensities Made of Relevance to Vascular Cognitive Impair-ment. Journal of the American Heart Association, 4, e001140.
[4] Steingart, A., Hachinski, V.C., Lau, C., et al. (1987) Cognitive and Neurologic Findings in Demented Patients with Diffuse White Matter Lucencies on Computed Tomo-graphic Scan (Leuko-Araiosis). Archives of Neurology, 44, 36-39. [Google Scholar] [CrossRef] [PubMed]
[5] Alber, J., Alladi, S., Bae, H.J., et al. (2019) White Matter Hyperintensities in Vascular Contributions to Cognitive Impairment and Dementia (VCID): Knowledge Gaps and Opportunities. Alzheimers Dement, 5, 107-117.
[6] 胡文立, 杨磊, 李譞婷, 黄勇华. 中国脑小血管病诊治专家共识2021[J]. 中国卒中杂志, 2021, 16(7): 716-726.
[7] Hu, H.Y., Ou, Y.N., Shen, X.N., et al. (2021) White Matter Hyperintensities and Risks of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of 36 Pro-spective Studies. Neuroscience & Biobehavioral Reviews, 120, 16-27. [Google Scholar] [CrossRef] [PubMed]
[8] Launer, L.J., Berger, K., Breteler, M.M., Dufouil, C., Fuhrer, R., Giampaoli, S., Nilsson, L.G., Pajak, A., de Ridder, M., van Dijk, E.J., Sans, S., Schmidt, R. and Hofman, A. (2006) Regional Variability in the Prevalence of Cerebral White Matter Lesions: An MRI Study in 9 European Countries (CASCADE). Neuroepidemiology, 26, 23-29. [Google Scholar] [CrossRef] [PubMed]
[9] 廖健颖, 朱蔚文, 李又福, 等. 皮质下缺血性脑血管病患者不同脑区脑白质病变与血管性认知功能损伤的相关性研究[J]. 实用心脑肺血管病杂志, 2020, 28(11): 48-53.
[10] Li, Q., Yang, Y., Reis, C., et al. (2018) Cerebral Small Vessel Disease. Cell Transplantation, 27, 1711-1722. [Google Scholar] [CrossRef] [PubMed]
[11] Simão, F., Ustunkaya, T., Clermont, A.C. and Feener, E.P. (2017) Plasma Kallikrein Mediates Brain Hemorrhage and Edema Caused by Tissue Plasminogen Activator Therapy in Mice af-ter Stroke. Blood, 129, 2280-2290. [Google Scholar] [CrossRef] [PubMed]
[12] Filley, C.M. and Fields, R.D. (2016) White Matter and Cogni-tion: Making the Connection. Journal of Neurophysiology, 116, 2093-2104. [Google Scholar] [CrossRef] [PubMed]
[13] Brown, R., Low, A. and Markus, H.S. (2021) Rate of, and Risk Fac-tors for, White Matter Hyperintensity Growth: A Systematic Review and Meta-Analysis with Implications for Clinical Trial Design. Journal of Neurology Neurosurgery and Psychiatry, 92, 1271-1277. [Google Scholar] [CrossRef] [PubMed]
[14] Tamura, A., Kuriyama, N., Akazawa, K., et al. (2021) A 10-Year Longitudinal Study of Deep White Matter Lesions on Magnetic Resonance Imaging. Neuroradiology, 63, 1599-1609. [Google Scholar] [CrossRef] [PubMed]
[15] Wardlaw, J.М., Smith, C. and Dichgans, M. (2019) Small Ves-sel Disease: Mechanisms and Clinical Implications. The Lancet Neurology, 18, 684-696. [Google Scholar] [CrossRef
[16] Ihara, M. and Yamamoto, Y. (2016) Emerging Evidence for Pathogenesis of Sporadic Cerebral Small Vessel Disease. Stroke, 47, 554-560. [Google Scholar] [CrossRef
[17] Kerkhofs, D., Wong, S.M., Zhang, E., et al. (2021) Base-line Blood-Brain Barrier Leakage and Longitudinal Microstructural Tissue Damage in the Periphery of White Matter Hy-perintensities. Neurology, 96, e2192-e2200. [Google Scholar] [CrossRef
[18] 任腊梅, 郭爱红, 高春燕, 丁江博, 王丙聚. 脑白质病变危险因素及发病机制的研究进展[J]. 中国实用神经疾病杂志, 2022, 25(7): 916-919.
[19] Walsh, J., Tozer, D.J., Sari, H., et al. (2021) Microglial Activation and Blood-Brain Barrier Permeability in Cerebral Small Vessel Disease. Brain, 144, 1361-1371. [Google Scholar] [CrossRef] [PubMed]
[20] Lin, L., Zhang, Y., Zeng, Q., et al. (2019) Atherosclerosis, Inflammatory Factor Changes, Cognitive Disorder and Vascular Endothelial Functions in Patients with Different Grades of Leukoaraiosis. Clinical Hemorheology and Microcirculation, 73, 591-597. [Google Scholar] [CrossRef
[21] Lin, J., Wang, D., Lan, L.F. and Fan, Y.H. (2017) Multiple Factors In-volved in the Pathogenesis of White Matter Lesions. BioMed Research International, 2017, Article ID: 9372050. [Google Scholar] [CrossRef] [PubMed]
[22] Freeze, W.M., Jacobs, H.I.L., De Jong, J.J., et al. (2020) White Matter Hyperintensities Mediate the Association between Blood-Brain Barrier Leakage and Information Processing Speed. Neurobiology of Aging, 85, 113-122. [Google Scholar] [CrossRef] [PubMed]
[23] Nowroozpoor, A., Gutterman, D. and Safdar, B. (2021) Is Microvascular Dysfunction a Systemic Disorder with Common Biomarkers Found in the Heart, Brain, and Kid-neys?—A Scoping Review. Microvascular Research, 134, Article ID: 104123. [Google Scholar] [CrossRef] [PubMed]
[24] Rachdaoui, N. (2020) Insulin: The Friend and the Foe in the De-velopment of Type 2 Diabetes Mellitus. International Journal of Molecular Sciences, 21, Article 1770. [Google Scholar] [CrossRef] [PubMed]
[25] Kumar, S., Mittal, A., Babu, D., et al. (2021) Herbal Medicines for Di-abetes Management and Its Secondary Complications. Current Diabetes Reviews, 17, 437-456. [Google Scholar] [CrossRef
[26] Schmidt, A.M. (2018) Highlighting Diabetes Mellitus: The Epidemic Continues. Arteriosclerosis, Thrombosis, and Vascular Biology, 38, e1-e8. [Google Scholar] [CrossRef
[27] Umemura, T., Kawamura, T. and Hotta, N. (2017) Patho-genesis and Neuroimaging of Cerebral Large and Small Vessel Disease in Type 2 Diabetes: A Possible Link between Cerebral and Retinal Microvascular Abnormalities. Journal of Diabetes Investigation, 8, 134-148. [Google Scholar] [CrossRef] [PubMed]
[28] Van, S.T.T., Sedaghat, S., Carnethon, M.R., Launer, L.J. and Stehouwer, C.D.A. (2020) Cerebral Microvascular Complications of Type 2 Diabetes: Stroke, Cognitive Dysfunction, and Depres-sion. The Lancet Diabetes and Endocrinology, 8, 325-336. [Google Scholar] [CrossRef
[29] 孟琳, 王雅楠, 龙晓月, 孙宝莹, 马原源, 刘斌. 糖调节受损及转甲状腺素蛋白与脑小血管病患者脑白质病变的相关性[J]. 中华老年心脑血管病杂志, 2023, 25(3): 281-285.
[30] Kabootari, M., Hasheminia, M., Azizi, F., Mir-bolouk, M. and Hadaegh, F. (2020) Change in Glucose Intolerance Status and Risk of Incident Cardiovascular Disease: Tehran Lipid and Glucose Study. Cardiovascular Diabetology, 19, Article No. 41. [Google Scholar] [CrossRef] [PubMed]
[31] Moroni, F., Ammirati, E., Hainsworth, A.H. and Camici, P.G. (2020) Association of White Matter Hyperintensities and Cardiovascular Disease: The Importance of Microcirculatory Disease. Circulation: Cardiovascular Imaging, 13, e010460. [Google Scholar] [CrossRef
[32] Fang, F., Wang, N., Yan, S., et al. (2019) Impaired Glucose Tolerance Predicts All-Cause Mortality among Older Men at High Risk for Cardiovascular Disease in China. Primary Care Diabetes, 13, 495-504. [Google Scholar] [CrossRef] [PubMed]
[33] Heringa, S.M., Bouvy, W.H., van den Berg, E., et al. (2013) Asso-ciations between Retinal Microvascular Changes and Dementia, Cognitive Functioning, and Brain Imaging Abnormalities: A Systematic Review. Journal of Cerebral Blood Flow & Metabolism, 33, 983-995. [Google Scholar] [CrossRef] [PubMed]
[34] 曹博雯, 孟旭霞. 不同类型的干细胞在糖尿病视网膜病变中的作用研究进展[J]. 中华眼底病杂志, 2018, 34(4): 415-421.
[35] 吕小涵, 滕振杰, 高文娟, 吕佩源. 视网膜病变与脑白质病变关系的研究进展[J]. 中国脑血管病杂志, 2023, 20(1): 49-53.
[36] Qiu, C., Cotch, M.F., Sigurdsson, S., et al. (2010) Cerebral Microbleeds, Retinopathy, and Dementia: The AGES- Reykjavik Study. Neurology, 75, 2221-2228. [Google Scholar] [CrossRef
[37] Wang, S., Li, G., Zuo, H., et al. (2019) Association of In-sulin, C-Peptide and Blood Lipid Patterns in Patients with Impaired Glucose Regulation. BMC Endocrine Disorders, 19, Article No. 75. [Google Scholar] [CrossRef] [PubMed]
[38] Selenius, J.S., Wasenius, N.S., Kautiainen, H., et al. (2020) Im-paired Glucose Regulation, Depressive Symptoms, and Health-Related Quality of Life. BMJ Open Diabetes Research and Care, 8, e001568. [Google Scholar] [CrossRef] [PubMed]
[39] Li, W., Wang, D., Wang, X., et al. (2019) The Association of Metabolic Syndrome Components and Diabete Mellitus: Evidence from China National Stroke Screening and Prevention Project. BMC Public Health, 19, Article No. 192. [Google Scholar] [CrossRef] [PubMed]
[40] Grosu, S., Lorbeer, R., Hartmann, F., et al. (2021) White Matter Hyperintensity Volume in Pre-Diabetes, Diabetes and Normoglycemia. BMJ Open Diabetes Research and Care, 9, e002050. [Google Scholar] [CrossRef] [PubMed]
[41] Wieczorek, E. and Ozyhar, A. (2021) Transthyretin: From Structural Stability to Osteoarticular and Cardiovascular Diseases. Cells, 10, Article 1768. [Google Scholar] [CrossRef] [PubMed]
[42] Wiliams, G.R. (2008) Neurodevelopmental and Neurophysiological Actions of Thyroid Hormone. Journal of Neuroendocrinology, 20, 784-794.
[43] Ge, J.F., Xu, Y.Y., Qin, G., Cheng, J.Q. and Chen, F.H. (2016) Resveratrol Ameliorates the Anxiety-and Depression-Like Behavior of Subclinical Hypo-thyroidism Rat: Possible Involvement of the HPT Axis, HPA Axis, and Wnt/β- Catenin Pathway. Frontiers in Endocri-nology, 24, Article 44. [Google Scholar] [CrossRef] [PubMed]
[44] 刘英. 甲状腺功能检测在心脑血管疾病中的应用和分析[J]. 中外医疗, 2010, 29(32): 34.
[45] 陈富春. 老年人甲状腺功能和心脑血管病间的关系[J]. 中外医疗, 2018, 37(20): 31-33.
[46] 姚纲, 严文斌, 闫锋, 等. 295例住院心脑血管病患者甲状腺疾病患病率的分析[J]. 中国当代医药, 2015(22): 172-174, 177.
[47] 肖伏龙, 高培毅. 甲状腺功能亢进症合并颅内动脉痉挛致脑梗死一例[J]. 中国现代神经疾病杂志, 2016, 16(1): 52-54.
[48] Chen, Y., Chang, J., Yin, R., et al. (2020) Diagnosis and Treatment of Low T3 Syndrome in Neurocritical Patients. Journal of Clinical Pharmacy and Therapeutics, 45, 759-766. [Google Scholar] [CrossRef] [PubMed]
[49] Ichiki, T. (2016) Thyroid Hormone and Vascular Remodeling. Journal of Atherosclerosis and Thrombosis, 23, 266- 275. [Google Scholar] [CrossRef] [PubMed]
[50] Ray, M. and Autieri, M.V. (2019) Regulation of Pro- and Anti-Atherogenic Cytokines. Cytokine, 122, Article ID: 154175. [Google Scholar] [CrossRef] [PubMed]
[51] 金凤, 肖萌. 血管性痴呆合并甲状腺功能减退发生率的研究[J]. 医学信息, 2018, 31(21): 106-108.
[52] Lau, D.H., Huynh, L.H., Chew, D.P., et al. (2009) Prognostic Impact of Types of Atrial Fibrillation in Acute Coronary Syndromes. The American Journal of Cardiology, 104, 1317-1323. [Google Scholar] [CrossRef] [PubMed]
[53] 易辉. 血清性激素水平检测在女性患者早期甲状腺功能减退诊断中的价值[J]. 中国医学创新, 2019, 16(27): 146-148.
[54] 王姗娜, 李美艺, 韩燕, 等. 女性脑小血管病与甲状腺功能相关性研究[J]. 中西医结合心血管病电子杂志, 2020, 8(25): 64, 66.
[55] Leonards, C.O. (2014) Thy-roid-Stimulating Hormone, White Matter Hyperintensities, and Functional Outcome in Acute Ischemic Stroke Patients. Cerebrovascular Diseases Extra, 4, 61-68. [Google Scholar] [CrossRef] [PubMed]
[56] Novella, S., Perez-Cremades, D., Mompeon, A., et al. (2019) Mechanisms Underlying the Influence of Oestrogen on Cardiovascular Physiology in Women. The Journal of Physiology, 597, 4873-4886. [Google Scholar] [CrossRef
[57] 刘承灵, 刘伟民, 上官亚菲, 等. 绝经后脑梗死患者的雌激素水平与纤维蛋白原水平的相关性研究[J]. 中国现代医生, 2019, 57(23): 19-22, 26.
[58] Crespo-Castrillo, A. and Arevalo, M.A. (2020) Microglial and Astrocytic Function in Physiological and Pathological Conditions: Estrogenic Modulation. International Journal of Molecular Sciences, 21, Article 3219. [Google Scholar] [CrossRef] [PubMed]
[59] Hewitt, S.C. and Korach, K.S. (2018) Estrogen Receptors: New Direc-tions in the New Millennium. Endocrine Reviews, 39, 664-675. [Google Scholar] [CrossRef] [PubMed]
[60] 顾华芬, 沈林娣, 姚叶红, 等. 围绝经期女性脑梗死患者危险因素及干预措施分析[J]. 中国妇幼保健, 2020, 35(19): 3642-3644.
[61] 林建武, 管晓斌. 绝经后脑梗死患者雌激素水平与血小板活化及聚集功能的相关性研究[J]. 中国妇幼保健, 2020, 35(10): 1828-1830.
[62] Deer, R.R. and Stallone, J.N. (2016) Effects of Estrogen on Cerebrovas-cular Function: Age-Dependent Shifts from Beneficial to Detrimental in Small Cerebral Arteries of the Rat. American Journal of Physiology-Heart and Circulatory Physiology, 310, H1285-H1294. [Google Scholar] [CrossRef] [PubMed]
[63] Raz, L. (2014) Estrogen and Cerebrovascular Regulation in Menopause. Molecular and Cellular Endocrinology, 389, 22-30. [Google Scholar] [CrossRef] [PubMed]
[64] 张利莎, 李珊珊, 李斌, 等. 缺血性脑白质病变的研究进展[J]. 中华脑科疾病与康复杂志(电子版), 2015, 5(2): 120-124.
[65] Wang, S., Zhang, Z., Wang, J., et al. (2022) Neuronal GPER Participates in Genistein-Mediated Neuro-protection in Ischemic Stroke by Inhibiting NLRP3 Inflammasome Activation in Ovariectomized Female Mice. Molecular Neurobiology, 59, 5024-5040. [Google Scholar] [CrossRef] [PubMed]